Global Cord Blood Corporation (CO) Reports Q2 Net Income of $19.5M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022
November 24, 2021 4:16 PM ESTAdded 19,066 New Subscribers in 2Q22Revenues Up 9.8% YoY to RMB313.7 Million ($48.7 Million)Â Â Â Â Â Â Â Â Gross Profit Up 11.0% YoY to RMB267.5 Million ($41.5 Million)Operating Income Up 15.3% YoY to RMB160.5 Million ($24.9 Million) Non-GAAP Operating Income Up 14.1% YoY to RMB172.8 Million ($26.8 Million)Conference Call to be Held on November 26, 2021, at 8:00 a.m. ET
HONG KONG, Nov. 24, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its... More
